Skip to main content
. 2014 Jul 17;5(16):6896–6908. doi: 10.18632/oncotarget.2229

Figure 1. Elevated BIRC6 expression is associated with advanced stages of prostate cancer: co-upregulation of other IAP members.

Figure 1

(A) Correlation of immunohistochemical staining intensity of BIRC6 and clinical (T) stages of prostate cancer (mean staining intensity ± S.E.M.). (B-D) Correlation of BIRC6 immunohistochemical staining intensity with the absence and presence of poor prognostic factors, such as recurrence of PSA, lymph node metastasis and prostatic capsule invasion. The statistical significance of positive trends was determined by the Chi square test for trend. (E) Representative images of correlated expressions between BIRC6 and survivin, XIAP and cIAP1. 20x magnification, scale bar, 100 μm.